Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 692.00
Bid: 687.00
Ask: 688.50
Change: 0.00 (0.00%)
Spread: 1.50 (0.218%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 692.00
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TATE & LYLE ACQUIRES SWEET GREEN FIELDS

1 Dec 2020 07:00

RNS Number : 0180H
Tate & Lyle PLC
01 December 2020
 

 

 

1 December 2020

 

TATE & LYLE ACQUIRES SWEET GREEN FIELDS

 

Position as a leading global provider of sugar reduction and clean-label solutions

strengthened by acquisition of stevia sweetener solutions business

 

London, UK, 1 December 2020 - Tate & Lyle PLC (Tate & Lyle), a leading global provider of food and beverage ingredients and solutions, is pleased to announce the acquisition of Sweet Green Fields (SGF), a leading global stevia solutions business.

 

The acquisition of SGF brings a broad portfolio of stevia products and a fully integrated stevia supply chain to Tate & Lyle including leaf sourcing, leaf varietal development, established agricultural programmes and cost-efficient manufacturing. It strengthens Tate & Lyle's position as a leading provider of innovative sweetener solutions with the capabilities to create foods and beverages that are lower in sugar and calories and with cleaner labels for customers across the world. The acquisition also extends Tate & Lyle's presence in the faster growing Asia Pacific region with dedicated stevia production and research and development facilities located in Anji, China.

 

Tate & Lyle began its partnership with SGF in 2017 becoming the exclusive global distributor of SGF's portfolio of stevia-based ingredients and solutions, and then acquired a 15% equity holding in SGF the following year. Tate & Lyle's acquisition of the remaining shares of SGF simplifies the existing relationship by creating a fully integrated supply chain and commercial organisation, unified research and development capabilities, and combined strengths to accelerate innovation and optimise production technologies. Sweet Green Fields revenue for the year ending 31 December 2020 is expected to be around US$50 million, including revenue for products Tate & Lyle currently sells as distribution agent.

 

Stevia is one of the fastest growing low-calorie sweeteners used globally, particularly in beverages, dairy and snacks, as demand from consumers continues to grow for foods and beverages that are lower in sugar and calories. Globally, from 2015 to 2019, product launches that contain stevia grew by compound annual growth rate of 15%.1 In the year ended 31 March 2020, Tate & Lyle's stevia revenues grew by 23%, making it an important contributor to New Products revenue growth.

Nick Hampton, Chief Executive, Tate & Lyle, said: "Sweet Green Fields is an exceptional business with a leading portfolio of stevia solutions, a strong team of stevia experts and an impressive, fully-integrated supply chain. We are delighted to take our relationship to the next level by bringing Sweet Green Fields into the Tate & Lyle family. This acquisition supports our strategy to grow our sweetener solutions portfolio and our purpose of Improving Lives for Generations by helping us to deliver tasty food and beverages with less sugar to consumers worldwide."

Dean Francis, Chief Executive, Sweet Green Fields, said: "I am proud of the leading stevia business that the Sweet Green Fields team has built. Tate & Lyle, with its global customer reach, innovation focus, and strong sweetener portfolio, is the ideal company to take Sweet Green Fields forward, supporting food and beverage customers across the globe and enabling healthier consumer diets." 

Notes to editors

1. Mintel GNPD

 

ENDS

For more information contactAnna Taylor-Elphick, Corporate PR Manageranna.taylor-elphick@tateandlyle.com / +44 (0) 7766 361 515Christopher Marsh, VP, Investor Relationschris.marsh@tateandlyle.com / +44 (0) 7796 192 688

About Tate & Lyle: Tate & Lyle PLC is a leading global provider of food and beverage ingredients and solutions. Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, mouthfeel and fibre fortification, our Food & Beverage Solutions business develops solutions which reduce sugar, calories and fat, add fibre, and provide texture and stability in categories including beverages, dairy, bakery, soups, sauces and dressings. Our Primary Products business produces nutritive sweeteners, industrial starches used in paper and packaging, acidulants and products used for animal nutrition.

We have around 4,200 employees working in more than 60 locations across 30 countries. Tate & Lyle's purpose is Improving Lives for Generations and through our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2020, Tate & Lyle sales totalled £2.9 billion. For more information, please visit http://www.tateandlyle.com or follow Tate & Lyle on Twitter or Linkedin.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQFFFEILFLIVII
Date   Source Headline
29th May 20147:01 amBUSEffect of Adoption of IFRS 11 ‘Joint Arrangements’
29th May 20147:00 amBUSFinal Results
1st May 201410:18 amBUSTotal Voting Rights
3rd Apr 20147:00 amBUSTrading Statement
2nd Apr 20144:45 pmBUSHolding(s) in Company
1st Apr 201410:25 amBUSTotal Voting Rights
5th Mar 20149:48 amBUSDirector/PDMR Shareholding
3rd Mar 201412:47 pmBUSDirector/PDMR Shareholding
20th Feb 20146:18 pmBUSHolding(s) in Company
17th Feb 201411:16 amBUSDirector/PDMR Shareholding
13th Feb 20142:58 pmBUSDirector/PDMR Shareholding
13th Feb 20147:01 amBUSInterim Management Statement
13th Feb 20147:00 amBUSNew Alliance with McNeil Nutritionals
13th Jan 201411:14 amBUSDirector/PDMR Shareholding
9th Jan 201412:54 pmBUSHolding(s) in Company
6th Jan 20143:34 pmBUSDirector/PDMR Shareholding
2nd Jan 201410:02 amBUSBlocklisting Interim Review
2nd Dec 201310:37 amBUSTotal Voting Rights
27th Nov 20135:13 pmBUSTransaction in Own Shares
26th Nov 20135:25 pmBUSTransaction in Own Shares
25th Nov 20136:04 pmBUSTransaction in Own Shares
22nd Nov 20135:23 pmBUSTransaction in Own Shares
21st Nov 20135:04 pmBUSTransaction in Own Shares
20th Nov 20135:22 pmBUSTransaction in Own Shares
19th Nov 20135:37 pmBUSTransaction in Own Shares
18th Nov 20135:37 pmBUSTransaction in Own Shares
8th Nov 20131:08 pmBUSDirector/PDMR Shareholding
7th Nov 20137:00 amBUSHalf-yearly Report
1st Nov 20139:06 amBUSTotal Voting Rights
4th Oct 20137:00 amBUSTrading Statement
30th Sep 201311:04 amBUSHolding(s) in Company
20th Sep 201312:02 pmBUSHolding(s) in Company
16th Aug 20139:21 amBUSHolding(s) in Company
5th Aug 20135:16 pmBUSDirector/PDMR Shareholding
1st Aug 201310:28 amBUSTotal Voting Rights
1st Aug 20139:18 amBUSDirector/PDMR Shareholding
24th Jul 20134:16 pmBUSResult of AGM
24th Jul 20137:00 amBUSInterim Management Statement
22nd Jul 20139:23 amBUSDirector/PDMR Shareholding
10th Jul 20139:03 amBUSDirector/PDMR Shareholding
8th Jul 20132:11 pmBUSHolding(s) in Company
5th Jul 20135:45 pmBUSDirector/PDMR Shareholding
4th Jul 20135:11 pmBUSTransaction in Own Shares
3rd Jul 20136:03 pmBUSTransaction in Own Shares
3rd Jul 20133:38 pmBUSDirector/PDMR Shareholding
2nd Jul 20135:17 pmBUSTransaction in Own Shares
1st Jul 20135:36 pmBUSTransaction in Own Shares
1st Jul 201310:08 amBUSBlocklisting Interim Review
1st Jul 20139:53 amBUSTotal Voting Rights
28th Jun 20135:32 pmBUSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.